
Evaluate the efficacy of a topical treatment protocol with zzso 50% to alleviate inflammatory processes in type 1 complex regional pain syndrome zzso with a course of less than 1 zzso 

zzso study performed in a zzso hospital on patients with type 1 zzso for whom a standard treatment zzso was prescribed with zzso administration of oral drugs and zzso zzso Patients also received topical zzso 50% cream as a zzso zzso The follow-up period, lasting until patient zzso or during 1 year for persistent cases, included 6 zzso zzso 15 days, 1 month, 3 months, 6 months, and 1 zzso The evaluation was performed using a visual analogue scale zzso as the main efficacy zzso Secondary variables were the zzso scale for quality of life and the limb capacity variable zzso of motion, strength, overall limb zzso A questionnaire designed for the study was also zzso 

zzso decrease in zzso score in the 29 patients was zzso zzso The zzso scale score increased by zzso zzso The scores measuring limb capacity increased to zzso for range of motion and to 3 in strength with overall function rated zzso 

zzso application of zzso 50% associated with a treatment zzso decreased pain intensity according to the zzso score with results approaching absence of pain, and led to higher scores on the quality of life zzso zzso zzso 50% is an additional tool for use in treating zzso zzso Its side effects are scarce and it provides an overall sense of relief and zzso zzso 

